These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Ghanem N, Altehoefer C, Högerle S, Nitzsche E, Lohrmann C, Schäfer O, Kotter E, Langer M. Eur J Radiol; 2005 May; 54(2):264-70. PubMed ID: 15837408 [Abstract] [Full Text] [Related]
12. MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT. Sofue K, Tateishi U, Tsurusaki M, Arai Y, Yamazaki N, Sugimura K. Eur J Radiol; 2012 Apr; 81(4):714-8. PubMed ID: 21353412 [Abstract] [Full Text] [Related]
17. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Rappeport ED, Loft A, Berthelsen AK, von der Recke P, Larsen PN, Mogensen AM, Wettergren A, Rasmussen A, Hillingsoe J, Kirkegaard P, Thomsen C. Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514 [Abstract] [Full Text] [Related]
19. Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis. Arita J, Ono Y, Takahashi M, Inoue Y, Takahashi Y, Matsueda K, Saiura A. Ann Surg; 2015 Dec; 262(6):1086-91. PubMed ID: 26010441 [Abstract] [Full Text] [Related]
20. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT. Pujara AC, Raad RA, Ponzo F, Wassong C, Babb JS, Moy L, Melsaether AN. Breast J; 2016 May; 22(3):264-73. PubMed ID: 26843433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]